Predictors of local recurrence after treatment of ductal carcinoma in situ - A meta-analysis

作者: John Boyages M.B.B.S. , Geoff Delaney M.B.B.S. , Richard Taylor M.B.B.S.

DOI: 10.1002/(SICI)1097-0142(19990201)85:3<616::AID-CNCR12>3.0.CO;2-7

关键词:

摘要: lBACKGROUND. Management of patients with ductal carcinoma in situ (DCIS) is a dilemma, as mastectomy provides nearly 100% cure rate but at the expense physical and psychologic morbidity. It would be helpful if we could predict which DCIS are sufficiently high risk local recurrence after conservative surgery (CS) alone to warrant postoperative radiotherapy (RT) sufficient CS + RT mastectomy. The authors reviewed published studies identified factors that may predictive management by mastectomy, alone, or RT. METHODS. examined patient, tumor, treatment potential predictors for estimated risks based on review studies. They effects patient (age diagnosis family history), tumor (sub-type DCIS, grade, size, necrosis, margins), (mastectomy, RT). 95% confidence intervals (CI) rates each were calculated subtype, using exact binomial; summary CI category quantitative meta-analysis fixed random models applied proportions. RESULTS, Meta-analysis yielded 22.5% (95% = 16.9-28.2) employing 8.9% 6.8-11.0) RT, 1.4% 0.7-2.1) involving alone. These figures indicate clear statistically significant separation, therefore outcome, between category, despite likelihood who underwent likely have had smaller, possibly low grade lesions margins. presence cytologic features, comedo subtype found derive greatest improvement control addition CS. Local among treated approximately 20%, one-half recurrences invasive cancers. For most patients, reduces least 50%. differences apparent those tumors close positive surgical CONCLUSIONS, recommend radiation added also choose breast conservation over suitable outside clinical trial little no Use statistics when discussing outcomes help make decisions. Cancer 1999;85:616-28. (C) 1999 American Society.

参考文章(72)
Kent C. Westbrook, H.Stephen Gallager, Intraductal carcinoma of the breast. A comparative study. American Journal of Surgery. ,vol. 130, pp. 667- 670 ,(1975) , 10.1016/0002-9610(75)90417-1
A Fourquet, M McNeese, R Amalric, A Recht, B McCormick, B A Bornstein, M E Taylor, R R Kuske, D J Schultz, L J Solin, B G Haffty, W Barrett, J M Kurtz, I T Yeh, B L Fowble, Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation. The cancer journal from Scientific American. ,vol. 2, pp. 158- 165 ,(1996)
Michael D. Lagios, Duct Carcinoma in Situ: Pathology and Treatment Surgical Clinics of North America. ,vol. 70, pp. 853- 871 ,(1990) , 10.1016/S0039-6109(16)45185-6
Jeffrey A. Sunshine, H.Stephens Moseley, William S. Fletcher, William W. Krippaehne, Breast carcinoma in situ. A retrospective review of 112 cases with a minimum 10 year follow-up. American Journal of Surgery. ,vol. 150, pp. 44- 51 ,(1985) , 10.1016/0002-9610(85)90008-X
Anita Ringberg, O Ljungberg, F Linell, B Palmer, Rychterova, Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ Ejso. ,vol. 17, pp. 20- 29 ,(1991)
L J Solin, J Kurtz, A Fourquet, R Amalric, A Recht, B A Bornstein, R Kuske, M Taylor, W Barrett, B Fowble, B Haffty, D J Schultz, I T Yeh, B McCormick, M McNeese, Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. Journal of Clinical Oncology. ,vol. 14, pp. 754- 763 ,(1996) , 10.1200/JCO.1996.14.3.754
P Price, HD Sinnett, B Gusterson, G Walsh, RP A'Hern, JA McKinna, Duct carcinoma in situ: predictors of local recurrence and progression in patients treated by surgery alone. British Journal of Cancer. ,vol. 61, pp. 869- 872 ,(1990) , 10.1038/BJC.1990.194
Frank A. Vicini, Mario D. Lacerna, Neal S. Goldstein, Eric M. Horwitz, Carl F. Dmuchowski, Julia R. White, Gregory S. Gustafson, John A. Ingold, Alvaro A. Martinez, Ductal carcinoma in situ detected in the mammographic era: an analysis of clinical, pathologic, and treatment-related factors affecting outcome with breast-conserving therapy. International Journal of Radiation Oncology Biology Physics. ,vol. 39, pp. 627- 635 ,(1997) , 10.1016/S0360-3016(97)00314-3